Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report : AIDS

Secondary Logo

Journal Logo

Advanced Search
Correspondence

Model-informed intermittent tenofovir disoproxil fumarate and emtricitabine dosing for HIV pre-exposure prophylaxis in subjects with renal impairment: a case report

Zino, Leenaa; Jacobs, Tom G.a; Nieuwenstein, Thomasa; Grintjes, Karinb; Colbers, Angelaa; Burger, David M.a

Author Information

aDepartment of Pharmacy

bDepartment of Internal Medicine, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Correspondence to Leena Zino, MSc, Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, 864 Radboudumc, Geert Grooteplein 10, 6525 GA Nijmegen, The Netherlands. Tel: +31 24 3611111; e-mail: [email protected]

Received 5 September, 2022

Revised 10 November, 2022

Accepted 18 November, 2022

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).

AIDS 37(2):p 363-365, February 1, 2023. | DOI: 10.1097/QAD.0000000000003438
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid